Misawa & Co. narrowed its parent net loss to 12 million yen for the six months ended July 31, a significant improvement from the 59 million yen loss reported during the same period last year. The results reflect a shift toward profitability as the company bolstered its top-line performance.
Poletowin Pitcrew Holdings swung to a net profit of 432 million yen for the six months ending July 31, marking a sharp recovery from the 392 million yen loss recorded during the same period last year. The Japanese firm’s financial turnaround highlights a stabilization in its core operational performance.
Nippon Telephone Inc. reported a parent net loss of 136 million yen for the nine-month period ending July 31, a significant improvement from the 238 million yen loss recorded during the same interval last year. The narrowing deficit reflects a period of revenue growth for the Japanese telecommunications firm.
Frontier International Inc. reported a sharp surge in profitability for the first quarter ending July 31, with net profit climbing to 333 million yen from 143 million yen during the same period last year. The results, calculated under Japanese accounting standards, reflect a significant expansion in the company's financial performance.
A 4.7 percent increase in net profit propelled Tomoe Engineering to 3.52 billion yen for the nine months ending July 31, despite a broader stagnation in operating and pretax margins. The results, filed under Japanese accounting standards, reflect a marginal rise in overall revenue to 46.81 billion yen.
Smaregi Inc. reported a significant financial expansion for the first quarter ending July 31, with net profit nearly doubling to 683 million yen compared to 385 million yen during the same period last year, according to the company's latest filing under Japanese accounting standards.
A 54 percent surge in net profit marks a standout fiscal year for Sanno Co. Ltd., as the Japanese manufacturer closed the period ending July 31 with 1.18 billion yen in earnings. This performance significantly outpaces the 765 million yen recorded in the previous fiscal cycle.
Danish pharmaceutical giant Novo Nordisk is shedding half its name to become simply Novo, a strategic pivot intended to sharpen the company's profile in the hyper-competitive market for obesity treatments. While the legal entity remains unchanged, the new branding signals a shift toward a more consumer-centric corporate identity.
Drone strikes on Saudi Arabia's East-West Pipeline and a tightening Houthi grip on the Bab al-Mandeb Strait have sent global energy markets into a tailspin. Brent crude climbed 2.9% to $107.68 a barrel on Monday, as supply anxieties compounded the impact of a deepening regional geopolitical impasse.
A 554 million yen net loss for the fiscal year ending July 31 marks a sharp reversal for Tokyo-based Link-U Inc., which posted a 147 million yen profit just one year prior. The company’s latest financial statement reveals a fundamental erosion of margins as operating costs outpaced modest revenue streams.
Kushim Inc. reported a significant reduction in its net losses for the nine months ending July 31, 2026, dropping to 347 million yen from the 1.05 billion yen deficit recorded during the same period last year. The Japanese firm’s improved bottom line coincides with a sharp increase in quarterly revenue.
Acrodea Inc. posted a net profit of 37 million yen for the first quarter ended July 31, a sharp reversal from the 156 million yen loss recorded during the same period last year. The Japanese firm’s financial turnaround was driven by significant revenue growth, which climbed to 1.67 billion yen.
Tamagawa Holdings Co. Ltd. posted a dramatic increase in profitability for the nine-month period ending July 31, with net profit climbing to 1.95 billion yen from 163 million yen a year prior. The Tokyo-listed firm’s performance reflects a substantial expansion across its core financial metrics throughout the 2026 fiscal year.
M-Mart Inc. reported a significant surge in profitability for the first half of the fiscal year ending July 31, with net profit reaching 252 million yen. This result marks a sharp increase from the 195 million yen recorded during the same period in the previous year, driven by expanding revenue streams.
A $450 million cash injection from the U.S. Department of Defense sent Elmet Group shares climbing 34% to $21.73 in Monday’s premarket trading. The capital infusion aims to shore up domestic production of tungsten, a critical material essential for the aerospace and defense sectors, reversing a recent three-month slump.
China Gas Holdings Limited has locked in a long-term supply agreement with Venture Global, committing to purchase 500,000 metric tons of liquefied natural gas annually. Starting in 2030, the two-decade deal deepens the energy partnership between the U.S. producer and the Chinese gas operator amid rising regional demand.
South San Francisco-based Electra Therapeutics is positioning itself for a significant market entry, offering 21.7 million shares at a projected range of $14 to $16. The biopharmaceutical firm aims to secure up to $341.9 million in capital, including shares allocated for underwriter options, to fuel its clinical development pipeline.
A strategic partnership between KKR and Realty Income will see the investment firm acquire a 49% stake in a portfolio of net lease assets across Europe. The transaction, valued at 528 million euros, signals a deepening commitment to the region’s commercial property market through a shared ownership structure.
A potential mechanical failure in Ford's F-150 lineup has triggered a massive safety recall, as fuel tanks on over 223,000 trucks may be improperly secured. The National Highway Traffic Safety Administration warned that these components could leak or detach entirely while the vehicle is in motion, creating significant road hazards.
Yields on 30-year U.K. government bonds climbed to their highest point since 1998 on Monday, as surging oil prices and mounting concerns over national borrowing costs spooked investors ahead of the upcoming autumn budget.
Shares of the French biotechnology firm Cellectis fell to $2.25 in premarket trading on Monday, dropping below their 52-week low. The sharp decline follows the company's decision to abandon its legacy cell therapy pipeline in favor of a total focus on in vivo gene editing technologies for metabolic and cardiovascular diseases.
Hain Celestial Group is offloading its international business for $323 million in cash, a move aimed at aggressive debt reduction and portfolio simplification. The announcement arrives alongside fourth-quarter results showing a narrowed loss of $61.9 million, providing a modest lift to investor sentiment following a difficult year for the stock.
A rare overture from Euronext CEO Stephane Boujnah regarding a potential tie-up with German rival Deutsche Boerse sparked immediate market optimism. Shares in both exchange operators climbed in midday trading as investors weighed the possibility of a combined entity capable of challenging U.S. dominance in the global financial sector.
Rum Group shares surged 17% in premarket trading Monday, hitting $8.37 following reports that the company secured a $13.7 billion computing deal with AI startup Anthropic. The agreement centers on leasing capacity at a data center currently under construction in Maysville, Georgia, confirming a mysterious contract disclosed in August.
Addus HomeCare has entered an agreement to purchase the personal care division of AccentCare for approximately $275 million. The deal, which excludes the seller’s hospice and home health operations, targets a significant expansion of the buyer's footprint across ten states, including key established markets in Texas, Illinois, and California.
A 42% jump in premarket trading greeted The Elmet Group on Monday, following news that the U.S. Department of Defense is injecting $450 million into the firm. This capital infusion arrives as the company struggles to recover from a 21% decline in its stock value over the past three months.
David Yeager is returning to the helm of Hub Group, reassuming his former role as chief executive officer. The transportation firm announced the leadership shift alongside a restructuring of its financial department, as the company works to resolve ongoing restatements and stabilize its executive suite following a turbulent spring.
Texas Capital Bancshares is abandoning Nasdaq to become one of the first major institutions to anchor the nascent Texas Stock Exchange. The Dallas-based financial firm plans to begin trading on the state-centric platform on October 8, signaling a departure from traditional coastal exchanges for a Texas-founded entity.
A 60-milligram daily dose of the experimental drug CRB-913 triggered a 5% mean weight loss among participants over 12 weeks, according to Phase 1b trial results released Monday. Corbus Pharmaceuticals now aims to position the treatment as a novel class of nonincretin oral medicine for obesity management.
Medtronic shareholders now have the opportunity to swap their holdings for MiniMed common stock at a 7% discount, a strategic maneuver designed to finalize the separation of the diabetes business. By shedding at least 80% of its stake, Medtronic seeks to sharpen its own focus on cardiovascular and neuroscience portfolios.
